Modelling Time to Recovery from Multidrug Resistant Tuberculosis in Southern Ethiopia

Shambel Selman Abdo, Denebo Sebaro Wanore, D. Teni, Lombamo Abebe Ejamo
{"title":"Modelling Time to Recovery from Multidrug Resistant Tuberculosis in Southern Ethiopia","authors":"Shambel Selman Abdo, Denebo Sebaro Wanore, D. Teni, Lombamo Abebe Ejamo","doi":"10.9734/jpri/2024/v36i67525","DOIUrl":null,"url":null,"abstract":"Introduction: Multidrug resistant tuberculosis (MDR-TB) is a global heath threat, resistant to key anti-TB drugs.  It is ranked among the top 10 causes of death worldwide. Therefore, the current study investigated time to recovery from MDR-TB in southern Ethiopia.\nData, Materials and Methods: Restrospective data from selected hospitals in SNNPR (January 2016 to December 2021) were analyzed. A cluster sample of 301 MDR-TB patients (131 NEMMCH, 121 BH, 49 AGH) was considered.\nResults: Among the 301 cases, 116 (38.5%) were censored. While 185 (61.5%) were recovered. Parametric shared frailty models were employed to account unobserved heterogeneity among the Hospitals and patients and AFT models were employed. the median recovery time of MDR-TB is 22 months. The clustering effect of frailty model was hospitals. Weibull-gamma shared frailty model was appropriate for this data.\nConclusion: The final model showed that males have higher recovery rates than females. Extra pulmonary MDR-TB and Urban residency correleted with  longer recovery times.  The recovery rate increases with increasing baseline weight, education level, and occupation. But, the recovery rate decreases with smoking, co-morbidities, previous drug history, history of TB, and alcohol use\nRecommendation: All concerned bodies should be cognizant on the risk factors of MDR-TB in SNNP region By providing on early case detection and appropriate treatment of drug-susceptible MDR-TB, since it is essential to shorten the recovery time of MDR-TB patients in line with WHO guidelines","PeriodicalId":16718,"journal":{"name":"Journal of Pharmaceutical Research International","volume":" 72","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Research International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/jpri/2024/v36i67525","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Multidrug resistant tuberculosis (MDR-TB) is a global heath threat, resistant to key anti-TB drugs.  It is ranked among the top 10 causes of death worldwide. Therefore, the current study investigated time to recovery from MDR-TB in southern Ethiopia. Data, Materials and Methods: Restrospective data from selected hospitals in SNNPR (January 2016 to December 2021) were analyzed. A cluster sample of 301 MDR-TB patients (131 NEMMCH, 121 BH, 49 AGH) was considered. Results: Among the 301 cases, 116 (38.5%) were censored. While 185 (61.5%) were recovered. Parametric shared frailty models were employed to account unobserved heterogeneity among the Hospitals and patients and AFT models were employed. the median recovery time of MDR-TB is 22 months. The clustering effect of frailty model was hospitals. Weibull-gamma shared frailty model was appropriate for this data. Conclusion: The final model showed that males have higher recovery rates than females. Extra pulmonary MDR-TB and Urban residency correleted with  longer recovery times.  The recovery rate increases with increasing baseline weight, education level, and occupation. But, the recovery rate decreases with smoking, co-morbidities, previous drug history, history of TB, and alcohol use Recommendation: All concerned bodies should be cognizant on the risk factors of MDR-TB in SNNP region By providing on early case detection and appropriate treatment of drug-susceptible MDR-TB, since it is essential to shorten the recovery time of MDR-TB patients in line with WHO guidelines
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
埃塞俄比亚南部耐多药结核病康复时间建模
导言:耐多药结核病(MDR-TB)是对主要抗结核药物产生耐药性的一种全球性健康威胁。 它被列为全球十大死因之一。因此,本研究调查了埃塞俄比亚南部耐多药结核病患者的康复时间:本研究分析了来自南方各族州选定医院的回顾性数据(2016 年 1 月至 2021 年 12 月)。结果:301 例 MDR-TB 患者(131 例 NEMMCH、121 例 BH、49 例 AGH)中,116 例(38 例 MDR-TB 患者)的康复时间为 3 个月:结果:在 301 个病例中,116 例(38.5%)被剔除。185例(61.5%)康复。采用参数共享虚弱模型来考虑医院和患者之间未观察到的异质性,并采用 AFT 模型。MDR-TB 的中位康复时间为 22 个月。虚弱模型的聚类效应是医院。Weibull-gamma 共享虚弱模型适用于该数据:最终模型显示,男性的康复率高于女性。肺外 MDR-TB 和城市居住与较长的康复时间相关。 恢复率随着基线体重、教育水平和职业的增加而增加。建议:建议:所有相关机构都应认识到 SNNP 地区 MDR-TB 的风险因素,根据世界卫生组织的指导方针,及早发现病例并适当治疗对药物敏感的 MDR-TB 患者,这对缩短 MDR-TB 患者的康复时间至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
735
期刊最新文献
Fabrication and Evaluation of Luliconazole Loaded Leciplex against Candidiasis Proanthocyanidins and Dental Health: Uncovering the Benefits Designing and Characterization of Docetaxel Loaded Nanoparticles with Piperine Determination of Heavy Metal Contamination of Some Commercially Available Herbal Preparations in Nigeria In vivo Antiplasmodial Assessment of Phyllanthus odontadenius against Plasmodium berghei in NMRI Mice
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1